Expanding access to HIV prevention for pregnant and postpartum women in Kenya
Scaling up integrated PrEP delivery in Kenyan maternal and child health clinics for pregnant and postpartum women
This study is working to make it easier for pregnant and new moms in Kenya to get a medicine called PrEP that helps prevent HIV, by teaming up with healthcare workers and the community to improve how it's offered in clinics.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11004700 on NIH RePORTER |
What this research studies
This research focuses on increasing the availability of pre-exposure prophylaxis (PrEP) for pregnant and postpartum women in Kenyan maternal and child health clinics. It aims to implement a comprehensive package of strategies to enhance the delivery of PrEP, which is crucial during these high-risk periods for HIV acquisition. The study will involve collaboration with healthcare workers and leverage community engagement to optimize the integration of PrEP into existing health services. By testing various implementation strategies, the research seeks to ensure that more women can access this vital preventive treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant and postpartum women in Kenya who are at high risk for HIV.
Not a fit: Patients who are not pregnant or postpartum, or those who are not at risk for HIV, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of HIV acquisition among pregnant and postpartum women, improving their health outcomes and that of their infants.
How similar studies have performed: Previous implementation science projects have successfully integrated PrEP into maternal and child health services, indicating a promising foundation for this scale-up effort.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Wagner, Anjuli Dawn — University of Washington
- Study coordinator: Wagner, Anjuli Dawn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.